Archives

by in
Entry Author Date Location
RNA Therapeutics Are Here to Stay 06/05/14 San Diego
East Coast Biotech Roundup: Bristol, PTC, Ophthotech, & More 05/27/14 Boston
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
Sarepta to Submit Application for Duchenne Drug, Shares Boom 04/21/14 Boston
Supreme Court Should Scale Back Securities Class Actions 03/04/14 National
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Building Biotechs to Last: The Photos 12/12/13 San Francisco
Building Biotechs to Last: See the Agenda for Monday 12/05/13 San Francisco
3 Life Sciences Companies That Are Built to Last 12/02/13 National
Building Biotechs to Last: A Sneak Peek at the Agenda for Dec. 9 11/19/13 San Francisco
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
In Defense of Sarepta’s Chris Garabedian 11/14/13 National
Sarepta Shares Crumble As FDA Calls New Drug Application “Premature” 11/12/13 Boston
Building Biotechs to Last: See Bonnie Anderson, Dan Bradbury & More 11/07/13 Boston
Lessons from the St. Louis Cardinals and ‘Building Biotechs to Last’ 10/30/13 San Francisco
Profiles in Perseverance: Building Biotechs to Last. Coming Dec. 9 10/18/13 San Francisco
Join Xconomy for Profiles in Biotech Perseverance in SF Dec. 9 10/03/13 National
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More 09/27/13 Boston
Biotech and Fantasy Football Picks for Fall 2013 09/03/13 National
East Coast Life Sciences Roundup: Sarepta, Agios, Gerngross, & (Much) More 07/26/13 Boston
Sarepta to Seek FDA Approval For Duchenne Muscular Dystrophy Drug 07/24/13 Boston
Xconomy Boston’s Top 20 Stories of Q2 2013: Editor’s Picks 07/01/13 Boston
East Coast Life Sciences Roundup: IPO Madness, Amicus, & More 06/21/13 Boston
PTC Therapeutics IPO Raises $125M Despite Checkered Past 06/20/13 New York
Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian 06/10/13 National
East Coast Life Sciences Roundup: ASCO, Follica, Aveo, & More 06/07/13 Boston
Foundation-Backed Dart Revs Up, Seeks Venture Funds 03/29/13 Boston
Page 1 of 2 next page »